Exclusive: A David Baker Spinout Launches AI Antibody Data Consortium with GSK, Boltz and Others

A-Alpha Bio, a startup spun out of David Baker’s lab, led by David Younger, has launched a first-of-its-kind AI antibody data consortium with GSK, Boltz Bio, Dyno Therapeutics, and Cradle. The initiative aims to accelerate AI-driven antibody discovery by generating and sharing large-scale experimental data among members.